查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1285861

骨科市场 - 2023-2031年全球行业分析、规模、份额、增长、趋势和预测

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 237 Pages | 商品交期: 2-10个工作天内

价格

骨科市场 - 报告范围

TMR关于全球骨科市场的报告研究了过去以及当前的增长趋势和机会，以获得对2023年至2031年预测期间市场指标的宝贵见解。报告提供了2017-2031年全球骨科市场的收入，考虑到2023年为基准年，2031年为预测年。报告还提供了2023年至2031年全球骨科市场的复合年增长率（CAGR %）。

该报告是在广泛研究后编写的。一级研究涉及大部分的研究工作，其中分析师与关键的意见领袖、行业领袖和意见制造者进行了访谈。二级研究包括参考主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解等离子体材料市场。

该报告深入研究了全球等离子体材料市场的竞争格局。在全球矫形外科市场运作的主要参与者已被确定，其中每一个都在各种属性方面进行了分析。公司概况、财务状况、最近的发展和SWOT是本报告中对全球矫形外科市场参与者的属性描述。

目录

第一章：前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目标
  • 研究重点

第二章：假设和研究方法

第三章：执行摘要：全球市场

第四章：市场概述

  • 简介
    • 细分市场的定义
  • 概述
  • 市场动态
    • 驱动力
    • 限制因素
    • 机会
  • 2017-2031年全球市场分析和预测
    • 市场收入预测

第五章：关键洞察力

  • 主要市场趋势
  • 合并与收购
  • 在市场上运营的前五名玩家的策略
  • 骨科疾病的发生率：按主要国家分类
  • 外科手术的数量
  • 主要国家的监管和报销情况
  • Covid-19大流行病对行业的影响

第六章：全球市场分析与预测：按产品分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按产品分类，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他产品
  • 市场吸引力分析：按产品分类

第七章 ：全球市场分析和预测：按应用分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按应用分类，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场吸引力分析：按应用分类

第八章：全球市场分析与预测：按终端用户分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场吸引力分析：按终端用户分类

第九章：全球市场分析和预测：按地区划分

  • 主要研究结果
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第十章：北美市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品分类，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他
  • 市场价值预测：按应用，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场价值预测：按国家划分，2017-2031年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按产品分类
    • 按应用分类
    • 按终端用户
    • 按国家分类

第11章 ：欧洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他
  • 市场价值预测：按应用，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场价值预测：按国家/次区域，2017-2031年
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按应用分类
    • 按终端用户
    • 按国家/次区域分类

第十二章 ：亚太地区市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他
  • 市场价值预测：按应用，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场价值预测：按国家/次区域，2017-2031年
    • 中国
    • 日本
    • 印度
    • 澳大利亚和新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按应用分类
    • 按终端用户
    • 按国家/次区域分类

第13章 ：拉美市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他
  • 市场价值预测：按应用，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场价值预测：按国家划分，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按应用分类
    • 按终端用户
    • 按国家/次区域分类

第十四章：中东和非洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按产品，2017-2031年
    • 异体移植
    • 异种移植
    • 合成骨移植
      • 羟基磷灰石
      • B-磷酸三钙(B-TCP)
      • 生物气
      • 生物活性玻璃
      • 其他
    • 去矿化骨基质(DBM)
    • 视觉补充剂
    • 富含血小板的血浆(PRP)
    • 骨髓浓缩液(BMAC)
    • 其他
  • 市场价值预测：按应用，2017-2031年
    • 脊柱融合
    • 创伤修复
    • 重建手术
    • 骨折
    • 骨关节炎
    • 颌面和牙科应用
    • 其他应用
  • 市场价值预测：按终端用户，2017-2031年
    • 医院
    • 骨科诊所
    • 其他
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按产品分类
    • 按应用分类
    • 按终端用户
    • 按国家/次区域分类

第十五章 ：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）。
  • 市场份额/排名分析：按公司，2022年
  • 公司简介
    • Alphatec Spine, Inc.
    • Arthrex
    • Bioventus LLC
    • Exactech, Inc.
    • Global Medical, Inc.
    • Integra Lifesciences
    • Medtronic
    • MTF Biologics
    • RTI Surgical
    • Sano Orthopedics
    • Sanofi
    • Seikagaku Corporation
    • Stryker
    • Zimmer Biomet
Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global Orthobiologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Orthobiologics Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Orthobiologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Orthobiologics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Orthobiologics market.

The report delves into the competitive landscape of the global Orthobiologics market. Key players operating in the global Orthobiologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Orthobiologics Market profiled in this report.

Key Questions Answered in Global Orthobiologics Market Report:

  • What is the sales/revenue generated by Orthobiologics across all regions during the forecast period?
  • What are the opportunities in the global Orthobiologics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global Orthobiologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Orthobiologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Orthobiologics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Market Trends
  • 5.2. Merger & Acquisition
  • 5.3. Strategies of Top Five Players Operating in the Market
  • 5.4. Incidence of Orthopedic Disorder, by Key Countries
  • 5.5. Number of Surgical Procedures
  • 5.6. Regulatory and Reimbursement Scenario by Key Countries
  • 5.7. Covid-19 Pandemic Impact on the Industry

6. Global Orthobiologics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Allografts
    • 6.3.2. Xenografts
    • 6.3.3. Synthetic Bone Grafts
      • 6.3.3.1. Hydroxyapatite
      • 6.3.3.2. B-tricalcium Phosphate (B-TCP)
      • 6.3.3.3. BiPhasic
      • 6.3.3.4. Bioactive Glass
      • 6.3.3.5. Others
    • 6.3.4. Demineralized Bone Matrix (DBM)
    • 6.3.5. Viscosupplementation
    • 6.3.6. Platelet-rich Plasma (PRP)
    • 6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Spinal Fusion
    • 7.3.2. Trauma Repair
    • 7.3.3. Reconstructive Surgeries
    • 7.3.4. Fractures
    • 7.3.5. Osteoarthritis
    • 7.3.6. Maxillofacial & Dental Applications
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Orthopedic Clinics
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Orthobiologics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Allografts
    • 10.2.2. Xenografts
    • 10.2.3. Synthetic Bone Grafts
      • 10.2.3.1. Hydroxyapatite
      • 10.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 10.2.3.3. BiPhasic
      • 10.2.3.4. Bioactive Glass
      • 10.2.3.5. Others
    • 10.2.4. Demineralized Bone Matrix (DBM)
    • 10.2.5. Viscosupplementation
    • 10.2.6. Platelet-rich Plasma (PRP)
    • 10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 10.2.8. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Spinal Fusion
    • 10.3.2. Trauma Repair
    • 10.3.3. Reconstructive Surgeries
    • 10.3.4. Fractures
    • 10.3.5. Osteoarthritis
    • 10.3.6. Maxillofacial & Dental Applications
    • 10.3.7. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Orthopedic Clinics
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Orthobiologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Allografts
    • 11.2.2. Xenografts
    • 11.2.3. Synthetic Bone Grafts
      • 11.2.3.1. Hydroxyapatite
      • 11.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 11.2.3.3. BiPhasic
      • 11.2.3.4. Bioactive Glass
      • 11.2.3.5. Others
    • 11.2.4. Demineralized Bone Matrix (DBM)
    • 11.2.5. Viscosupplementation
    • 11.2.6. Platelet-rich Plasma (PRP)
    • 11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 11.2.8. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Spinal Fusion
    • 11.3.2. Trauma Repair
    • 11.3.3. Reconstructive Surgeries
    • 11.3.4. Fractures
    • 11.3.5. Osteoarthritis
    • 11.3.6. Maxillofacial & Dental Applications
    • 11.3.7. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Orthopedic Clinics
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Orthobiologics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Allografts
    • 12.2.2. Xenografts
    • 12.2.3. Synthetic Bone Grafts
      • 12.2.3.1. Hydroxyapatite
      • 12.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 12.2.3.3. BiPhasic
      • 12.2.3.4. Bioactive Glass
      • 12.2.3.5. Others
    • 12.2.4. Demineralized Bone Matrix (DBM)
    • 12.2.5. Viscosupplementation
    • 12.2.6. Platelet-rich Plasma (PRP)
    • 12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 12.2.8. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Spinal Fusion
    • 12.3.2. Trauma Repair
    • 12.3.3. Reconstructive Surgeries
    • 12.3.4. Fractures
    • 12.3.5. Osteoarthritis
    • 12.3.6. Maxillofacial & Dental Applications
    • 12.3.7. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Orthopedic Clinics
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Orthobiologics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Allografts
    • 13.2.2. Xenografts
    • 13.2.3. Synthetic Bone Grafts
      • 13.2.3.1. Hydroxyapatite
      • 13.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 13.2.3.3. BiPhasic
      • 13.2.3.4. Bioactive Glass
      • 13.2.3.5. Others
    • 13.2.4. Demineralized Bone Matrix (DBM)
    • 13.2.5. Viscosupplementation
    • 13.2.6. Platelet-rich Plasma (PRP)
    • 13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 13.2.8. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Spinal Fusion
    • 13.3.2. Trauma Repair
    • 13.3.3. Reconstructive Surgeries
    • 13.3.4. Fractures
    • 13.3.5. Osteoarthritis
    • 13.3.6. Maxillofacial & Dental Applications
    • 13.3.7. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Orthopedic Clinics
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Allografts
    • 14.2.2. Xenografts
    • 14.2.3. Synthetic Bone Grafts
      • 14.2.3.1. Hydroxyapatite
      • 14.2.3.2. B-tricalcium Phosphate (B-TCP)
      • 14.2.3.3. BiPhasic
      • 14.2.3.4. Bioactive Glass
      • 14.2.3.5. Others
    • 14.2.4. Demineralized Bone Matrix (DBM)
    • 14.2.5. Viscosupplementation
    • 14.2.6. Platelet-rich Plasma (PRP)
    • 14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
    • 14.2.8. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Spinal Fusion
    • 14.3.2. Trauma Repair
    • 14.3.3. Reconstructive Surgeries
    • 14.3.4. Fractures
    • 14.3.5. Osteoarthritis
    • 14.3.6. Maxillofacial & Dental Applications
    • 14.3.7. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Orthopedic Clinics
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share/Ranking Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Alphatec Spine, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Arthrex
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. Bioventus LLC
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. Exactech, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Global Medical, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. Integra Lifesciences
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Medtronic
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. MTF Biologics
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. RTI Surgical
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Sano Orthopedics
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview
    • 15.3.11. Sanofi
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Strategic Overview
    • 15.3.12. Seikagaku Corporation
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Strategic Overview
    • 15.3.13. Stryker
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Strategic Overview
    • 15.3.14. Zimmer Biomet
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Strategic Overview

List of Tables

  • Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017-2031, by Application
  • Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Orthobiologics Market Value Share, by Product, 2021
  • Figure 03: Global Orthobiologics Market Value Share, by Application, 2021
  • Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021
  • Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023-2031 
  • Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Company Share Analysis, 2021